Trials / Completed
CompletedNCT03073486
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 744 (actual)
- Sponsor
- Dermira, Inc. · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olumacostat Glasaretil Gel, 5.0% | Gel containing Olumacostat Glasaretil |
| OTHER | Olumacostat Glasaretil Gel, Vehicle | Vehicle (placebo) gel |
Timeline
- Start date
- 2017-02-06
- Primary completion
- 2017-12-21
- Completion
- 2017-12-21
- First posted
- 2017-03-08
- Last updated
- 2021-07-20
- Results posted
- 2019-02-05
Locations
46 sites across 3 countries: United States, Australia, Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03073486. Inclusion in this directory is not an endorsement.